Introduction

Donated organs face a race against time once removed from the body. A new study reveals that machine perfusion can biologically rejuvenate livers, potentially improving transplant outcomes and expanding the usable donor pool.

What Happened

Researchers used aging clocks — tools that measure biological age through epigenetic patterns and gene activity — to compare donated livers kept on ice versus those run on perfusion machines for six to twelve hours. The perfused organs consistently showed a lower biological age, even when the donors were older or had less-than-ideal health histories.

In initial experiments, 37 samples from 19 livers revealed a striking pattern: machine-perfused livers had a younger biological age than non-perfused livers from younger donors. A follow-up analysis of 208 samples from 103 livers confirmed the result, with biopsies taken before and after transplantation. According to the clocks, pumping livers at 34°C with oxygen and nutrients reversed biological age by roughly 30 percent when adjusted for chronological age.

The benefits persisted after transplant. Despite an expected rise in biological age once the organ entered the recipient's body, perfused livers remained younger than their non-perfused counterparts.

Why This Matters

Organ shortage remains a critical challenge in transplantation. Perfusion technology already allows surgeons to evaluate organ quality and keep livers viable outside the body, but this research suggests the advantages go further — perfusion may actively reverse some aspects of organ aging.

Molecular analysis revealed changes in pathways linked to inflammation, tissue structure, and autophagy — the cellular cleanup process that removes damaged components. These shifts help explain why perfused organs tend to function better post-transplant.

Cost remains a barrier: perfusion can run $80,000 to $100,000 per organ in the U.S., and around €10,000 in Germany. However, the ability to safely use livers from older donors, including those over 70 or after circulatory death, is already reshaping transplant protocols.

Key Takeaways

  • Machine perfusion can lower the biological age of donated livers, making them functionally younger than chronologically younger non-perfused organs.
  • Epigenetic and gene-expression aging clocks detected the reversal, with effects lasting after transplantation.
  • Perfusion triggers molecular changes in inflammation control, tissue maintenance, and cellular recycling — all factors that influence transplant success.
  • Expanding the donor pool to include older or higher-risk livers could significantly reduce waitlist deaths.
  • Despite high costs, the technology is already changing clinical practice and enabling the use of organs once considered too old or damaged.

Conclusion

As scientists refine methods to measure and modify organ biology, perfusion may become a standard tool for optimizing every donated liver. The goal is not only to save more lives but to make each transplant more successful, regardless of the donor's age or medical history.